Ameritox

PAINWeek: September 5-8, 2012 | Las Vegas, NV

PAINWeek® attracts more than 1,500 physicians, nursing professionals, physician assistants, dentists, pharmacists, and psychologists with an interest in Pain Management.

Ameritox at PAINWeek 2012:

  • Exhibitor at booth #114
  • Symposium Sponsorship: Recommendations for Urine Drug Monitoring as a Component of Opioid Therapy in the Treatment of Chronic Pain
  • Poster Presentation: Analysis of Illicit Substance Abuse and Medication Monitoring By Payer Type

Stop by Ameritox booth #114 to speak to an Ameritox representative, meet with a member of Ameritox’s medical team and learn more about pain medication monitoring.  Or, if you are attending PAINWeek, you can schedule a meeting with an Ameritox representative by filling out the form below.

PAINWeek Information
Dates: September 5-8, 2012
Location: The Cosmopolitan of Las Vegas
Web Site: www.painweek.org

Symposium: “Recommendations for Urine Drug Monitoring as a Component of Opioid Therapy in the Treatment of Chronic Pain”
Published in Pain Medicine July 2012 Issue

Friday, September 7, 2012 | 12:30 pm – 2:00 pm
Condesa 3-4 – Level 2 / The Cosmopolitan of Las Vegas

Engage in an expert panel discussion of new recommendations that address urine drug monitoring as a component of opioid therapy, including:

  • Whom to test
  • How to test patients
  • When to test
  • How to interpret results, including potential differential diagnoses based on urine drug monitoring results
  • How to handle discrepancies in test results

Presented and Hosted by: John F. Peppin, DO, FACP; Steven D. Passik, PhD; Paul J. Christo, MD, MBA; Daniel Bennett, MD; Martin D. Cheatle, PhD

Development of these recommendations was supported by Ameritox, Inc. through an unrestricted grant.
The program does not offer CME/CE credit.
This satellite symposium is neither sponsored nor endorsed by PAINWeek®.


 
Your Information
Practice Information
Meeting Information